BriaCell Therapeutics Corp - New (BCTX) Income Statement (2021 - 2026)
Income Statement report data from Oct 31, 2021 to Apr 30, 2026 for BriaCell Therapeutics Corp - New (BCTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Apr 30, 2026 | Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||
Research And Development | 5.97M (-1.32%) | 6.05M (-9.43%) | 6.68M (-6.05%) | 7.11M (+47.82%) | 4.81M (-15.32%) | 5.68M (+54.77%) | 3.67M (-16.78%) | 4.41M (-42.43%) | 7.66M (-7.26%) | 8.26M (+20.41%) | 6.86M (+32.69%) | 5.17M (+33.94%) | 3.86M (+26.56%) | 3.05M (-6.44%) | 3.26M (+2.84%) | 3.17M (+39.65%) | 2.27M (+32.75%) | 1.71M (+94.32%) | 880K |
Selling General And Administrative | 1.65M (+11.49%) | 1.48M (-9.76%) | 1.64M (+13.89%) | 1.44M (-5.26%) | 1.52M (+2.70%) | 1.48M (-0.67%) | 1.49M (+9.56%) | 1.36M (-13.38%) | 1.57M (0.00%) | 1.57M (-4.85%) | 1.65M (-35.04%) | 2.54M (+39.56%) | 1.82M (+27.27%) | 1.43M (-33.49%) | 2.15M (+3.86%) | 2.07M (+11.89%) | 1.85M (-4.64%) | 1.94M (+37.59%) | 1.41M |
Operating Expenses | 7.62M (+1.20%) | 7.53M (-9.50%) | 8.32M (-2.69%) | 8.55M (+35.07%) | 6.33M (-11.72%) | 7.17M (+39.22%) | 5.15M (-10.75%) | 5.77M (-37.49%) | 9.23M (-6.10%) | 9.83M (+15.65%) | 8.50M (+10.25%) | 7.71M (+35.74%) | 5.68M (+26.50%) | 4.49M (-16.85%) | 5.40M (+3.25%) | 5.23M (+26.94%) | 4.12M (+12.88%) | 3.65M (+60.09%) | 2.28M |
Depreciation And Amortization | - | - | 20K (-71.43%) | 70K | - | - | 20K (-66.67%) | 60K | - | - | - | - | - | - | - | 10K | - | - | - |
Operating Income | |||||||||||||||||||
Operating Income | -7.62M (+1.20%) | -7.53M (-9.50%) | -8.32M (-2.69%) | -8.55M (+35.07%) | -6.33M (-11.72%) | -7.17M (+39.22%) | -5.15M (-10.75%) | -5.77M (-37.49%) | -9.23M (-6.10%) | -9.83M (+15.65%) | -8.50M (+10.25%) | -7.71M (+35.74%) | -5.68M (+26.50%) | -4.49M (-16.85%) | -5.40M (+3.25%) | -5.23M (+26.94%) | -4.12M (+12.88%) | -3.65M (+60.09%) | -2.28M |
Ebit | -7.62M (+1.20%) | -7.53M (-9.50%) | -8.32M (-2.69%) | -8.55M (+35.07%) | -6.33M (-11.72%) | -7.17M (+39.22%) | -5.15M (-10.75%) | -5.77M (-37.49%) | -9.23M (-6.10%) | -9.83M (+15.65%) | -8.50M (+10.25%) | -7.71M (+35.74%) | -5.68M (+26.50%) | -4.49M (-16.85%) | -5.40M (+3.25%) | -5.23M (+26.94%) | -4.12M (+12.88%) | -3.65M (+60.09%) | -2.28M |
EBITDA | -7.13M (-1.25%) | -7.22M (-13.01%) | -8.30M (-13.54%) | -9.60M (+57.64%) | -6.09M (-3.18%) | -6.29M (+22.61%) | -5.13M (-66.21%) | -15.18M | 1.72M | -11.29M (+32.82%) | -8.50M | 1.87M | -4.90M (-58.75%) | -11.88M (+120.00%) | -5.40M (-61.81%) | -14.14M (+41.12%) | -10.02M | 11M | -2.28M |
Other Income / Expenses | |||||||||||||||||||
Interest Income | 220K (+100.00%) | 110K (+120.00%) | 50K (+66.67%) | 30K (0.00%) | 30K (-40.00%) | 50K (+400.00%) | 10K | - | 20K (-75.00%) | 80K (-57.89%) | 190K (-9.52%) | 210K (-16.00%) | 250K (+4.17%) | 240K (+26.32%) | 190K (+137.50%) | 80K (+100.00%) | 40K (+300.00%) | 10K (0.00%) | 10K |
Interest Expense | 30K | - | - | - | 40K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 220K (+100.00%) | 110K (+120.00%) | 50K (+66.67%) | 30K (0.00%) | 30K (-40.00%) | 50K (+400.00%) | 10K | - | 20K (-75.00%) | 80K (-57.89%) | 190K (-9.52%) | 210K (-16.00%) | 250K (+4.17%) | 240K (+26.32%) | 190K (+137.50%) | 80K (+100.00%) | 40K (+300.00%) | 10K (0.00%) | 10K |
Other Non Operating Income | 190K (+137.50%) | 80K (-50.00%) | 160K (+45.45%) | 110K | -10.00K | 70K (+600.00%) | 10K (-96.15%) | 260K (+2500.00%) | 10K (-87.50%) | 80K (-55.56%) | 180K (-78.82%) | 850K (+8.97%) | 780K | -7.40M | 4.30M | -11.55M (+96.10%) | -5.89M | 15M | -25.25M |
Net Income | |||||||||||||||||||
Income Before Tax | - | - | - | 27M | - | - | - | 4.93M | - | - | - | 20M | - | - | - | -26.84M | - | - | - |
Net Income From Continuing Operations | -7.16M (-0.83%) | -7.22M (-11.95%) | -8.20M (+1.36%) | -8.09M (+31.97%) | -6.13M (-2.54%) | -6.29M (+8.45%) | -5.80M (+379.34%) | -1.21M | 1.72M | -11.29M | 6.00M | -2.42M (-50.61%) | -4.90M (-58.75%) | -11.88M (+970.27%) | -1.11M (+146.67%) | -450.00K (-95.51%) | -10.02M | 11M | -27.53M |
Net Income | -7.16M (-0.83%) | -7.22M (-11.95%) | -8.20M (+1.36%) | -8.09M (+31.97%) | -6.13M (-2.54%) | -6.29M (+8.45%) | -5.80M (+379.34%) | -1.21M | 1.72M | -11.29M | 6.00M | -2.42M (-50.61%) | -4.90M (-58.75%) | -11.88M (+970.27%) | -1.11M (+146.67%) | -450.00K (-95.51%) | -10.02M | 11M | -27.53M |
Comprehensive Income Net Of Tax | - | - | - | - | - | - | - | - | - | - | - | - | -4.90M (-58.75%) | -11.88M | - | - | -10.02M | 11M | - |